Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat clinical trial phase will the University of Oxford's ovarian cancer vaccine reach by end of 2025?
Preclinical • 25%
Phase 1 • 25%
Phase 2 • 25%
Phase 3 or beyond • 25%
Clinical trial registries such as ClinicalTrials.gov
University of Oxford Develops World's First Vaccine to Wipe Out Ovarian Cancer
Oct 4, 2024, 05:27 AM
Scientists at the University of Oxford in the UK are developing the world's first ovarian cancer vaccine, which researchers say could potentially eradicate the disease. The vaccine works by teaching the immune system to recognize and attack the earliest stages of ovarian cancer.
View original story